JPMORGAN CHASE & CO - CARIBOU BIOSCIENCES INC ownership

CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 95 filers reported holding CARIBOU BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is 0.94 and the average weighting 0.2%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of CARIBOU BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$2,735,966
+8.7%
572,378
-3.3%
0.00%
Q2 2023$2,516,774
-21.4%
592,182
-1.8%
0.00%
Q1 2023$3,202,000
+84856.2%
602,978
+0.5%
0.00%
Q4 2022$3,769
-99.9%
600,097
-0.2%
0.00%
-100.0%
Q3 2022$6,343,000
+129.2%
601,350
+18.0%
0.00%
Q2 2022$2,767,000
-41.6%
509,568
-1.2%
0.00%
-100.0%
Q1 2022$4,735,000
+1634.4%
515,758
+2754.9%
0.00%
Q4 2021$273,000
+61.5%
18,066
+155.7%
0.00%
Q3 2021$169,0007,0640.00%
Other shareholders
CARIBOU BIOSCIENCES INC shareholders Q4 2021
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 674,196$10,174,0006.39%
72 Investment Holdings, LLC 474,067$7,154,0006.35%
Velan Capital Investment Management LP 210,695$3,179,0002.47%
PFM Health Sciences, LP 4,092,309$59,418,0002.02%
Monashee Investment Management LLC 504,377$7,611,0001.88%
CloudAlpha Capital Management Limited/Hong Kong 415,000$6,262,0001.49%
Avidity Partners Management LP 2,674,067$40,352,0000.86%
Rokos Capital Management LLP 570,359$8,604,0000.52%
Green Alpha Advisors, LLC 35,592$537,0000.36%
Tekla Capital Management LLC 699,377$9,875,0000.32%
View complete list of CARIBOU BIOSCIENCES INC shareholders